advertisement
Zhang SD 10
Showing records 1 to 10 | Display all abstracts from Zhang SD80716 Rapamycin Removes Damaged Mitochondria and Protects Human Trabecular Meshwork (TM-1) Cells from Chronic Oxidative Stress
He JN
Molecular Neurobiology 2019; 56: 6586-6593
81250 Preliminary efficacy of penetrating canaloplasty in primary angle-closure glaucoma
Cheng HH
Chinese Journal of Ophthalmology 2019; 55: 448-453
80716 Rapamycin Removes Damaged Mitochondria and Protects Human Trabecular Meshwork (TM-1) Cells from Chronic Oxidative Stress
He JN; Zhang SD
Molecular Neurobiology 2019; 56: 6586-6593
81250 Preliminary efficacy of penetrating canaloplasty in primary angle-closure glaucoma
Hu C; Meng JY
Chinese Journal of Ophthalmology 2019; 55: 448-453
80716 Rapamycin Removes Damaged Mitochondria and Protects Human Trabecular Meshwork (TM-1) Cells from Chronic Oxidative Stress
Qu Y; Wang HL
Molecular Neurobiology 2019; 56: 6586-6593
81250 Preliminary efficacy of penetrating canaloplasty in primary angle-closure glaucoma
Zhang SD; Lin SG
Chinese Journal of Ophthalmology 2019; 55: 448-453
80716 Rapamycin Removes Damaged Mitochondria and Protects Human Trabecular Meshwork (TM-1) Cells from Chronic Oxidative Stress
Tham CC; Pang CP
Molecular Neurobiology 2019; 56: 6586-6593
81250 Preliminary efficacy of penetrating canaloplasty in primary angle-closure glaucoma
Bao JY
Chinese Journal of Ophthalmology 2019; 55: 448-453
80716 Rapamycin Removes Damaged Mitochondria and Protects Human Trabecular Meshwork (TM-1) Cells from Chronic Oxidative Stress
Chu WK
Molecular Neurobiology 2019; 56: 6586-6593
81250 Preliminary efficacy of penetrating canaloplasty in primary angle-closure glaucoma
Xie YQ; Le RR; Ye C; Liang YB
Chinese Journal of Ophthalmology 2019; 55: 448-453
